articleTop 1% cited
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
European Urology · 2017 · Vol. 72(4) · pp. 544–554
Roland Seiler✉(University of Bern)H.A.D.M. Ashab(Genome British Columbia)Nicholas Erho(Genome British Columbia)Bas W.G. van Rhijn(The Netherlands Cancer Institute)Brian Winters(University of Washington)James J. DouglasKim E. Van Kessel(Erasmus MC)Elisabeth E. Fransen van de Putte(The Netherlands Cancer Institute)Matthew SommerladNatalie Q. Wang(Genome British Columbia)Voleak Choeurng(Genome British Columbia)Ewan A. Gibb(Genome British Columbia)Beatrix Palmer-Aronsten(Genome British Columbia)Lucia L.C. Lam(Genome British Columbia)Christine Buerki(Genome British Columbia)Elai Davicioni(Genome British Columbia)Gottfrid Sjödahl(Lund University)Jordan Kardos(University of North Carolina at Chapel Hill)Katherine A. Hoadley(University of North Carolina at Chapel Hill)Seth P. Lerner(Baylor College of Medicine)David J. McConkey(The University of Texas MD Anderson Cancer Center)Woonyoung Choi(The University of Texas MD Anderson Cancer Center)William Y. Kim(Erasmus MC)Bernhard Kiss(University of Bern)George N. Thalmann(University of Bern)Tilman Todenhöfer(University of British Columbia)Simon J. CrabbScott NorthEllen C. Zwarthoff(Erasmus MC)Joost L. Boormans(Erasmus MC)Jonathan L. Wright(University of Washington)Marc Dall’EraMichiel S. van der Heijden(The Netherlands Cancer Institute)Peter C. Black
Bladder and Urothelial Cancer TreatmentsColorectal Cancer Screening and DetectionUrinary and Genital Oncology StudiesSubtypingMedicineBladder cancerConcordanceOncologyProportional hazards modelInternal medicineHazard ratioSurgical oncologyContext (archaeology)
MeSH terms
Exome SequencingAgedUrinary Bladder NeoplasmsFemaleHumansMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingPhenotypePredictive Value of TestsRetrospective StudiesRisk FactorsROC CurveTime Factors
Citations
780
FWCI
86.31
field-weighted impact
References
20
Percentile
100%
vs. same field & year
Citations per year
Cited by
Treatment of muscle‐invasive and advanced bladder cancer in 2020
CA A Cancer Journal for Clinicians · 2020 · 1,120 citations
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
European Urology · 2019 · 1,318 citations
References
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Cancer Cell · 2014 · 1,717 citations
A Molecular Taxonomy for Urothelial Carcinoma
Clinical Cancer Research · 2012 · 986 citations
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Journal of Clinical Oncology · 2012 · 2,632 citations
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
The Lancet Oncology · 2017 · 1,734 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.